Mode
Text Size
Log in / Sign up

Case report describes rhodesiense sleeping sickness in U.S. traveler returning from ZimbabweA U.S. traveler returned from Zimbabwe with sleeping sickness. What happened?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: This single case report documents a rare imported infection but provides no data for clinical guidance.

This is a descriptive case report of a single patient: a U.S. traveler returning from Zimbabwe diagnosed with rhodesiense human African trypanosomiasis (sleeping sickness). The report describes 1 case. No details are provided regarding the specific intervention or exposure, comparator, treatment course, or clinical outcomes. Safety and tolerability information is not reported. The follow-up duration is also not reported.

Key limitations are inherent to the study design. This is a single case report without a control group, comparative data, or statistical analysis. No causal inferences, effect sizes, or measures of efficacy or safety can be drawn. The findings cannot be generalized to other populations.

Regarding practice relevance, this report solely documents the occurrence of a rare, imported parasitic infection. It does not provide evidence to guide diagnosis, treatment, or prevention. Clinicians should be aware that rhodesiense sleeping sickness can occur in travelers from endemic regions like parts of Zimbabwe, but this report offers no comparative or outcome data to inform management.

Imagine returning from an African safari with more than just photos—with a serious, potentially fatal illness. That's what happened to one U.S. traveler who came home from Zimbabwe with rhodesiense human African trypanosomiasis, better known as sleeping sickness. This disease is caused by a parasite transmitted by the bite of infected tsetse flies, and it can affect the brain and nervous system if not treated.

The medical team documented this single case, noting the person had traveled to Zimbabwe, a country where this form of sleeping sickness is known to occur. The report doesn't tell us about the traveler's symptoms, what treatment they received, or how they recovered. It also doesn't mention any safety issues or side effects from care, as those details weren't included.

It's crucial to understand this is just one person's experience. A case report like this can't tell us how often travelers get this disease, what makes someone more likely to get it, or which treatments are most effective. It serves as an important reminder for travelers to areas with tsetse flies to take preventive measures, like wearing protective clothing, and for doctors to consider this diagnosis when a returning traveler is sick. But we shouldn't draw broad conclusions from a single story.

What this means for you:
A single U.S. traveler got sleeping sickness in Zimbabwe. One case doesn't show risk or best treatment.

Study Details

EvidenceLevel 5
PublishedMar 2025
View Original Abstract ↓
This report describes a case of rhodesiense human African trypanosomiasis among a U.S. traveler returning from Zimbabwe.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.